DE3853582D1 - Verfahren zur diagnose von leberkrebs oder leberzirrhose. - Google Patents

Verfahren zur diagnose von leberkrebs oder leberzirrhose.

Info

Publication number
DE3853582D1
DE3853582D1 DE3853582T DE3853582T DE3853582D1 DE 3853582 D1 DE3853582 D1 DE 3853582D1 DE 3853582 T DE3853582 T DE 3853582T DE 3853582 T DE3853582 T DE 3853582T DE 3853582 D1 DE3853582 D1 DE 3853582D1
Authority
DE
Germany
Prior art keywords
liver
cirrus
diagnosing
cancer
liver cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3853582T
Other languages
English (en)
Other versions
DE3853582T2 (de
Inventor
Atusi Nisikawa
Naoyuki Taniguti
Isamu Takagahara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oriental Yeast Co Ltd
Original Assignee
Oriental Yeast Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oriental Yeast Co Ltd filed Critical Oriental Yeast Co Ltd
Application granted granted Critical
Publication of DE3853582D1 publication Critical patent/DE3853582D1/de
Publication of DE3853582T2 publication Critical patent/DE3853582T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57469—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving tumor associated glycolinkage, i.e. TAG
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE3853582T 1987-09-07 1988-09-06 Verfahren zur diagnose von leberkrebs oder leberzirrhose. Expired - Fee Related DE3853582T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP62221992A JP2579497B2 (ja) 1987-09-07 1987-09-07 肝臓疾患診断剤
PCT/JP1988/000898 WO1989002474A1 (en) 1987-09-07 1988-09-06 Method for diagnosis of cancer diseases

Publications (2)

Publication Number Publication Date
DE3853582D1 true DE3853582D1 (de) 1995-05-18
DE3853582T2 DE3853582T2 (de) 1995-11-02

Family

ID=16775387

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3853582T Expired - Fee Related DE3853582T2 (de) 1987-09-07 1988-09-06 Verfahren zur diagnose von leberkrebs oder leberzirrhose.

Country Status (5)

Country Link
US (1) US4994374A (de)
EP (1) EP0334962B1 (de)
JP (1) JP2579497B2 (de)
DE (1) DE3853582T2 (de)
WO (1) WO1989002474A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5403717A (en) * 1987-08-11 1995-04-04 Pacific Northwest Research Diagnosis of premalignant or malignant conditions of human secretory epithelia
US4971905A (en) * 1987-08-11 1990-11-20 Pacific Northwest Research Foundation Diagnosis of cancerous or precancerous conditions in human secretory epithelia by enzyme activity of β-1-3N-acetylglucosaminyltransferase
US5206356A (en) * 1988-11-21 1993-04-27 Chembiomed, Ltd. Inhibitors for alpha-L-fucosyl transferase
US5032505A (en) * 1988-11-21 1991-07-16 Chembiomed, Ltd. Inhibitors for glycosaminosyl transferase V
JPH05508398A (ja) * 1990-05-11 1993-11-25 ザ ユニバーシティ オブ コネチカット 細胞毒からの標的保護
JP3020811B2 (ja) * 1993-08-23 2000-03-15 寳酒造株式会社 糖鎖構造決定方法
US5856112A (en) * 1994-06-16 1999-01-05 Urocor, Inc. Method for selectively inducing biomarker expression in urologic tumor tissue for diagnosis and treatment thereof
AU6942598A (en) * 1997-03-31 1998-10-22 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The O-linked glcnac transferase (ogt): cloning, molecular expression, and methods ofuse
GB9919597D0 (en) * 1999-08-18 1999-10-20 Oxford Glycosciences Uk Ltd Methods and compositions for diagnosis of hepatoma
US20020037850A1 (en) * 2000-02-15 2002-03-28 Vernet Corine A. M. Novel polypeptides and nucleic acids encoding same
US20030190715A1 (en) * 2000-10-12 2003-10-09 Grosse William M. Novel proteins and nucleic acids encoding same
WO2002081669A1 (en) * 2001-04-03 2002-10-17 Sankyo Company, Limited Assay methods for o-g1cnac transferase activity
FI20011671A (fi) 2001-08-20 2003-02-21 Carbion Oy Tuumorispesifiset oligosakkaridisekvenssit ja niiden käyttö
WO2004017810A2 (en) * 2002-08-20 2004-03-04 Biotie Therapies Corp. Tumor specific oligosaccharide epitopes and use thereof
KR100475642B1 (ko) * 2001-12-29 2005-03-10 한국생명공학연구원 암 발생 및 전이에 관여하는 단백질의 당쇄 변화를측정하여 암을 진단하는 방법 및 이를 이용한 진단킷트
JP4628098B2 (ja) 2002-07-03 2011-02-09 イルミゲン バイオサイエンシズ，インコーポレイティド 肝細胞癌を診断する方法と組成物
US9944713B2 (en) 2004-11-24 2018-04-17 Medicinal Bioconvergence Research Center Antibody specific to the AIMP2-DX2
EP2224235A4 (de) * 2007-11-30 2011-04-20 Univ Hokkaido Nat Univ Corp Verfahren zur diagnose einer leberkrankheit mittels zuckerkettenanalyse
JP4930453B2 (ja) * 2008-05-12 2012-05-16 トヨタ自動車株式会社 回転軸の軸受潤滑構造
US20120058916A1 (en) 2009-05-13 2012-03-08 Meso Scale Technologies, Llc. Diagnostic methods for liver disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63152998A (ja) * 1986-12-16 1988-06-25 Konica Corp 糖転移酵素の測定方法

Also Published As

Publication number Publication date
DE3853582T2 (de) 1995-11-02
WO1989002474A1 (en) 1989-03-23
EP0334962B1 (de) 1995-04-12
JP2579497B2 (ja) 1997-02-05
US4994374A (en) 1991-02-19
EP0334962A4 (en) 1991-05-08
EP0334962A1 (de) 1989-10-04
JPS6465454A (en) 1989-03-10

Similar Documents

Publication Publication Date Title
DE3853582D1 (de) Verfahren zur diagnose von leberkrebs oder leberzirrhose.
DE3481453D1 (de) Verfahren zur platzierung von elementen.
DE3687519T2 (de) Verfahren zur beurteilung von knochen.
DE3575423D1 (de) Verfahren zur herstellung von heteroaryloxyacetamiden.
DE3765566D1 (de) Verfahren zur stromlosen plattierung.
DE3586638D1 (de) Verfahren zur herstellung von vanadylphthalocyanin.
DE3779671T2 (de) Verfahren zur gewinnung von gallium.
DE3765097D1 (de) Verfahren zur fabrikation von basisschmieroelen.
DE3586614T2 (de) Verfahren zur diagnose von krebs.
DE3888845D1 (de) Verfahren zur entmodulierung.
DE3780593D1 (de) Verfahren zur verhinderung von ablagerungen.
DE68901508D1 (de) Verfahren zur gewichtsdosierung.
DE58901598D1 (de) Verfahren zur gewinnung von rohargon.
DE3382044D1 (de) Verfahren zur pruefung von freien liganden.
DE3585219D1 (de) Verfahren zur herstellung von n-formyl-alpha-aspartyl-phenylalaninen.
DE341096T1 (de) Verfahren zur identifizierung von individuellen objekten oder gebieten.
DE3673060D1 (de) Verfahren zur rueckgewinnung von fluorwasserstoff.
DE3579858D1 (de) Verfahren zur herstellung von p-isobutylstyrol.
DE3875551T2 (de) Verfahren zur bestimmung der teilchengroesse.
DE233581T1 (de) Verfahren zur herstellung von l-threonin oder l-isoleucin.
DE3778274D1 (de) Verfahren zur repraesentation von bewegten bildern.
DE3865439D1 (de) Verfahren zur gewinnung von alkansulfonamiden.
DE341092T1 (de) Verfahren zur identifizierung von spezifischen objekten oder gebieten.
DE3673192D1 (de) Verfahren zur bilddarstellung der information.
DE3581667D1 (de) Verfahren zur herstellung von 5-deoxy-l-arabinose.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee